Xeomin prescribing information
Xeomin
Published by
Last Updated On September 25, 2024

Xeomin Prescribing Information

Sep 11, 2024

Accurate prescribing information is vital in cosmetic treatments, helping reduce adverse effects and boost patient satisfaction. Clear and precise guidelines play a crucial role in ensuring that treatments are both safe and effective, ultimately enhancing overall patient outcomes.

Xeomin, a botulinum toxin type A, is widely recognized in cosmetology for its effectiveness in treating glabellar lines, crow’s feet, and cervical dystonia. Proper administration of Xeomin, guided by detailed prescribing information, is essential for healthcare professionals to minimize risks and optimize results.

This article provides a comprehensive guide to Xeomin prescribing information, including its indications, dosage, administration techniques, and potential side effects. It equips practitioners and patients with the knowledge needed for safe and successful treatments.

Key Takeaways

  • Xeomin, known scientifically as incobotulinumtoxinA, is a botulinum toxin type A approved for both medical and cosmetic uses.
  • It is used to treat conditions like cervical dystonia, chronic sialorrhea, and frown lines between the eyebrows (glabellar lines).
  • Xeomin provides long-lasting relief and has a unique formulation lacking unnecessary proteins that may trigger immune resistance.
  • It is important to note contraindications for Xeomin, such as allergies to botulinum toxin, active infection at the injection site, pregnancy, breastfeeding, and certain neuromuscular disorders.
  • Potential risks and complications of Xeomin include difficulty swallowing or breathing, severe allergic reactions, and spread of toxin effects.
Consult our sales team if you’re interested in this product. Book a Meeting
ML LOGO

About: Trusted by over 2,000+ global clients since 2014, Maylips has become a leading supplier of cosmetic, skincare, and orthopedic products for medical and aesthetic professionals. Maylips offers a wide range of authentic brand-name products at competitive wholesale prices, sourced from around the world. If you’re looking to buy Xeomin online, contact our sales team for guidance.

What is Xeomin?

Xeomin, known scientifically as incobotulinumtoxinA, is a botulinum toxin approved for both medical and cosmetic uses. Medically, it is used to treat conditions like cervical dystonia, which causes uncontrollable neck muscle contractions, and chronic sialorrhea (excessive drooling), where it is injected into the salivary glands to reduce symptoms.

Cosmetically, Xeomin is widely used to minimize the appearance of frown lines between the eyebrows (glabellar lines). Treatments are typically administered every 12 weeks, making Xeomin suitable for both first-time and returning users.

Like other botulinum toxin products such as Botox and Dysport, Xeomin provides long-lasting relief, but it stands out due to its unique formulation, which lacks unnecessary proteins that may trigger immune resistance, potentially enhancing its effectiveness over time.

Indications for Use

Xeomin is approved for both medical and cosmetic applications, primarily working by relaxing targeted muscles where it is injected. Here are the main approved uses of Xeomin:

  • Cervical Dystonia: Xeomin effectively treats cervical dystonia, a condition characterized by severe neck pain and abnormal head positioning. It helps relax the overactive muscles, providing relief for adults, including those who have previously tried similar botulinum toxin treatments.
  • Chronic Drooling (Sialorrhea): Xeomin is approved for adults with chronic drooling due to salivary gland issues. It is injected into the saliva glands to significantly reduce excessive saliva production.
  • Frown Lines: For cosmetic use, Xeomin is FDA-approved to temporarily reduce moderate to severe glabellar lines (frown lines) between the eyebrows in adults seeking a smoother, more youthful appearance.

Beyond these approved uses, Xeomin is also utilized off-label for various cosmetic purposes, including reducing forehead lines, crow’s feet, and lip lines, similar to other botulinum toxin products like Botox. These off-label applications are not FDA-approved but are widely practiced by healthcare professionals for enhancing overall facial aesthetics.

Contraindications

Xeomin is a widely used botulinum toxin, but it is not suitable for everyone. Certain patient groups should avoid Xeomin due to potential risks and complications that could compromise their health. Here are the main contraindications:

  • Allergy to Botulinum Toxin: Patients with known allergies to botulinum toxin products or any components of Xeomin should not receive the injections, as this could trigger severe allergic reactions.
  • Active Infection at the Injection Site: Xeomin should not be administered to individuals with an active infection, inflammation, or skin condition at the intended injection site, as this could increase the risk of infection spreading.
  • Pregnancy and Breastfeeding: There is insufficient data on the safety of Xeomin during pregnancy or breastfeeding. Therefore, avoiding the treatment during these times is generally advised unless the benefits significantly outweigh the risks.
  • Neuromuscular Disorders: Patients with neuromuscular conditions such as myasthenia gravis, amyotrophic lateral sclerosis (ALS), or Lambert-Eaton syndrome are at higher risk of severe side effects, including prolonged muscle weakness and respiratory complications.

Potential Risks and Complications

Administering Xeomin in contraindicated patients or incorrect settings can lead to serious complications, including:

  • Difficulty Swallowing or Breathing: This can occur, particularly in patients with underlying neuromuscular disorders, due to the spread of toxin effects beyond the injection site.
  • Severe Allergic Reactions: Symptoms such as rash, itching, swelling, severe dizziness, or trouble breathing may indicate an allergic reaction and require immediate medical attention.
  • Spread of Toxin Effects: Rarely, the effects of Xeomin can spread to areas away from the injection site, leading to muscle weakness, blurred vision, drooping eyelids, and loss of bladder control.

Dosing Recommendations

Xeomin dosing varies depending on the condition being treated and the patient’s individual needs. Proper dosing is crucial for achieving the desired therapeutic or cosmetic outcomes while minimizing potential side effects.

For therapeutic uses, Xeomin is administered in specific doses based on the condition being treated:

  • Cervical Dystonia: The initial recommended dose is 120 units, divided among affected muscles. Dosage may be adjusted based on the patient’s response and tolerance.
  • Blepharospasm: The starting dose is typically 25 units per eye, injected into the orbicularis oculi muscle. Adjustments can be made based on the severity of the condition and patient response.

Dosing Considerations for Cosmetic Procedures

For cosmetic purposes, Xeomin is used in lower doses to safely and effectively achieve the desired aesthetic improvements:

  • Forehead Lines: Typically, 10-20 units are injected across the forehead to smooth horizontal lines.
  • Frown Lines (Glabellar Lines): A common dosage is 20 units, divided into five injections around the glabellar area.
  • Crow’s Feet: Usually, 12 units per side are administered to treat the lines around the eyes.

Administration Guidelines

Proper administration of Xeomin is essential for achieving optimal results and minimizing risks. Understanding the correct injection techniques and providing thorough patient counseling are key components of effective treatment.

  • Identify Xeomin Injection Sites: Precise placement of Xeomin injection sites is crucial for both therapeutic and cosmetic outcomes. For frown lines, inject into the corrugator and procerus muscles; for cervical dystonia, target affected neck muscles.
  • Use the Correct Needle: A fine-gauge needle, such as 30 or 32 gauge, is recommended to reduce discomfort and improve precision during injection.
  • Aseptic Technique: Always maintain a sterile environment, cleanse the skin thoroughly with antiseptic, and avoid areas with infections or inflammation.
  • Injection Depth and Angle: Administer Xeomin at the appropriate depth and angle based on the targeted muscles. Subtle injections may be required for cosmetic use, while deeper injections are used for therapeutic applications.

Patients should be informed about what to expect during and after the treatment. They should avoid rubbing or massaging the Xeomin injection sites for at least 24 hours to prevent the toxin from spreading to unintended areas. Additionally, patients should be advised to avoid strenuous activities and excessive sun exposure for a few days post-treatment to ensure the best results.

Conclusion

Xeomin is a reliable option for both medical and cosmetic treatments. It offers effective relief for muscle conditions and helps achieve smoother, wrinkle-free skin. Proper administration and individualized dosing are essential to maximize benefits and ensure patient safety.

Healthcare professionals should adhere to recommended guidelines and tailor treatments to each patient’s specific needs. Reviewing the full prescribing information before any procedure ensures the highest standards of care and optimal results.

FAQs

1. What is the difference between Xeomin and Botox? 

Xeomin and Botox are used for cosmetic purposes but differ in formulation and effects. Understanding these differences is essential when selecting a treatment.

2. Can Xeomin be used for crow’s feet? 

Yes, Xeomin is effective for treating crow’s feet, helping reduce the appearance of fine lines around the eyes.

3. What are the advantages and disadvantages of using Xeomin? 

Xeomin effectively reduces wrinkles, but like any treatment, it carries potential side effects that should be evaluated beforehand.

Need help, additional info, or customized deals?

Talk with our sales representative.

Book a Meeting

References

HIGHLIGHTS of PRESCRIBING INFORMATION. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125360s073lbl.pdf 

Xeomin Prescribing Information. Drugs.com. https://www.drugs.com/pro/Xeomin.html. Last updated July 24, 2024. Accessed September 11, 2024.